NCT05258500

Brief Summary

The goal of this feasibility study is to evaluate the use of the Ghostly app in rehabilitation of stroke patients, elderly and patients recovering from COVID-19 or ICU patients. In three randomized controlled trials, the effect of a strength training program incorporated in the Ghostly app will be assessed for 1) stroke patients suffering from weakness of the lower limb, 2) frail elderly with gait difficulties and 3) patients recovering from COVID-19 or ICU patients who suffer from muscle weakness. Additionally, the effect of BFR on strength gain in all these three populations will be tested.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
1.3 years until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

November 5, 2021

Last Update Submit

March 12, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in muscle strength from baseline to 2 weeks of intervention

    Muscle strength of the quadriceps muscle will be measured using the MicroFET dynamometer

    From baseline to 2 weeks of intervention

  • Change in muscle strength from baseline to 6 weeks of intervention or when the participants is discharged from the hospital

    Muscle strength of the quadriceps muscle will be measured using the MicroFET

    From baseline to 6 weeks of intervention or when the participant is discharged from the hospital

Secondary Outcomes (19)

  • Change in cross sectional area of the muscle from baseline to 2 weeks of intervention

    From baseline to 2 weeks of intervention

  • Change in cross sectional area of the muscle from baseline to 6 weeks of intervention or when the participants is discharged from the hospital

    From baseline to 6 weeks of intervention or when the participant is discharged from the hospital

  • Change in pennation angle from baseline to 2 weeks of intervention

    From baseline to 2 weeks of intervention

  • Change in pennation angle from baseline to 6 weeks of intervention or when the participants is discharged from the hospital

    From baseline to 6 weeks of intervention or when the participant is discharged from the hospital

  • Change in echo intensity from baseline to 2 weeks of intervention

    From baseline to 2 weeks of intervention

  • +14 more secondary outcomes

Other Outcomes (1)

  • Feasibility of the research protocol

    Up to 6 weeks of intervention

Study Arms (3)

Ghostly

EXPERIMENTAL

The first arm consists of a strength training program incorporated in the Ghostly game that will be given to the patient to be completed without supervision of the therapist as an added exercise program to their conventional therapy.

Other: Ghostly app

Blood flow restriction and Ghoslty

EXPERIMENTAL

The second intervention arm incorporates blood flow restriction into the conventional therapy using the Smart Cuffs PRO system (Smart Tools, USA). Additionally, these participants will receive additional exercises added to their conventional therapy using the Ghostly game

Other: Ghostly appOther: Blood flow restriction

Control

ACTIVE COMPARATOR

The control group will not be given the Ghostly game as additional exercises to complete after their conventional therapy, but will receive instructions for a strength training program targeting the same muscles as both intervention groups.

Other: Leaflet

Interventions

For the Ghostly app, we include three different trainings (standard, cluster set 1, cluster set 2). The standard training consists of three sets in which twelve muscle contractions are performed with 120 seconds of rest between each set. Each set of twelve contractions will be considered as one level in the game that needs to be ended before taking rest of 120s. Subsequently, the 'Cluster set 1' training is based on the training modalities of cluster set training since evidence shows that similar results can be obtained using cluster set training compared to standard training. The Cluster sets 1 and 2 also consist of 3 sets of twelve repetitions, but with ten seconds of rest between each contraction or 30 seconds of rest after three consecutive contractions respectively. The intensity at which will be trained is 75% of maximum voluntary contraction.

Blood flow restriction and GhosltyGhostly

Patients will complete four sets of 15 repetitions, with each contraction lasting three seconds. Similar to the first experimental group and control group, the training intensity will be set at 100%MVC with two minutes of rest between sets. The cuff pressure will be set at 50% of arterial occlusion pressure.

Blood flow restriction and Ghoslty
LeafletOTHER

This training program will be matched with the Ghostly game in terms of repetitions, sets and inter-set rest and will be given to the patient to complete without supervision of the therapist.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized
  • Subacute/acute stroke
  • Score of 19 or lower on the knee and hip movement test of the Motricity Index

You may not qualify if:

  • Unable to understand the instructions
  • Other disabilities (muscular, orthopedic, …)
  • Pregnancy
  • Metal implants
  • Implanted electrical devices
  • Hospitalized
  • + yrs
  • or less repetitions on the 30 seconds sit-to-stand test
  • Unable to understand the instructions
  • Other disabilities (muscular, orthopedic, …)
  • Metal implants
  • Implanted electrical devices
  • Hospitalized
  • Recovering from COVID-19 or ICU patient
  • score of 2 or less for manual muscle testing of the quadriceps muscle in both legs
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vrije Universiteit Brussel

Jette, Brussels Capital, 1090, Belgium

Location

University Hospital Brussels

Brussels, 1090, Belgium

Location

MeSH Terms

Conditions

StrokeCOVID-19FrailtyMuscle WeaknessSarcopenia

Interventions

Blood Flow Restriction Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsMuscular AtrophyAtrophyPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Eva Swinnen, Prof. Ph.D

    Vrije Universiteit Brussel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The Principal Investigator

Study Record Dates

First Submitted

November 5, 2021

First Posted

February 28, 2022

Study Start

July 1, 2023

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations